Abstract
The monosaccharide O‐linked N‐acetyl glucosamine (O‐GlcNAc) is an essential and dynamic post‐translational modification (PTM) that decorates thousands of nucleocytoplasmic proteins. Interrogating the role of O‐GlcNAc on a target protein is crucial yet challenging to perform in cells. We recently reported a pair of methods to selectively install or remove O‐GlcNAc on a target protein in cells using an engineered O‐GlcNAc transferase (OGT) or split O‐GlcNAcase (OGA) fused to a nanobody. Target protein O‐GlcNAcylation and de‐O‐GlcNAcylation complements methods to interrogate the role of O‐GlcNAc on a global scale or at individual glycosites. Herein, we describe a protocol for utilizing the nanobody‐OGT and nanobody‐splitOGA systems to screen for O‐GlcNAc functionality on a target protein. We additionally include associated protocols for the detection of O‐GlcNAc and cloning procedures to adapt the method for the user's target protein of interest. © 2021 Wiley Periodicals LLC.This article was corrected on 28 July 2022. See the end of the full text for details.Basic Protocol 1: Target protein O‐GlcNAcylation of JunB using nanobody‐OGTBasic Protocol 2: Target protein deglycosylation of Nup62 using nanobody‐splitOGAAlternate Protocol: Verification of the O‐GlcNAc state of a tagged target protein through chemoenzymatic labelingSupport Protocol: Cloning of new nanobody‐OGT/nanobody‐splitOGA and target protein pairs
Funding Information
  • National Institutes of Health (U01CA242098‐01)
  • Camille and Henry Dreyfus Foundation
  • Harvard University

This publication has 28 references indexed in Scilit: